AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

3.45
Delayed Data
As of May 21
 +0.04 / +1.17%
Today’s Change
2.96
Today|||52-Week Range
11.65
-48.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues1.1M2.4M29.5M5.2M
 
 
 
 
 
Depreciation And Amortization513.0K605.0K593.0K866.0K
 
 
 
 
 
 
Operating ExpensesGross Income--1.8M28.9M--
 
 
 
General Expenses19.9M31.5M35.6M42.0M
 
 
 
 
 
Research And Development13.6M24.9M26.3M24.5M
 
 
 
 
 
Total Operating Expenses20.4M32.1M36.2M42.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.4M-29.7M-6.7M-37.6M
 
 
 
 
 
Extraordinary Credit0.000.000.007.6M
 
 
Extraordinary Charge0.000.00-15.3M0.00
 
 
Interest Expense On Debt2.3M3.7M1.5M2.6M
 
 
 
 
 
Other Expenses1.5M0.0032.0K-651.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.1M-33.4M-23.4M-33.4M
 
 
 
 
 
Net Income-20.1M-33.4M-23.4M-33.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.3M22.1M39.7M43.4M
 
 
 
 
 
Shares To Calculate EPS Diluted17.3M22.1M39.7M44.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.16-$1.51-$0.59-$0.91
 
 
 
 
 
EPS Diluted-$1.16-$1.51-$0.59-$0.91
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account